Defence Therapeutics Inc.
DTC
Rang în acțiuni
#29535
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Preț acțiune
$0.25964327
Capitalizare de piață
$19.68M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-55.64%
Țară
CA
Tranzacționează Defence Therapeutics Inc. (DTC)
Categorie
Healthcare
Istoric al prețului acțiunii pentru Defence Therapeutics Inc. (DTC)
Cel mai mare preț de închidere: $0.27 pe 2026-10-01
Cel mai mic preț de închidere: $2.50 pe 2021-05-01
Cel mai mic preț de închidere: $2.50 pe 2021-05-01
Istoric al prețului acțiunii pentru Defence Therapeutics Inc. din 2021 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2026 (TTM) | -27.55% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.25 | -3.37% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
